Minerva Neurosciences, Inc.
NERV
$3.33
$0.082.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 925.40K | 1.30M | 1.36M | 1.98M | 1.89M |
| Gross Profit | -925.40K | -1.30M | -1.36M | -1.98M | -1.89M |
| SG&A Expenses | 1.92M | 2.08M | 2.54M | 2.54M | 2.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.84M | 3.37M | 3.90M | 4.52M | 4.37M |
| Operating Income | -2.84M | -3.37M | -3.90M | -4.52M | -4.37M |
| Income Before Tax | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.74M | -3.26M | -3.75M | -4.27M | 22.51M |
| EBIT | -2.84M | -3.37M | -3.90M | -4.52M | -4.37M |
| EBITDA | -2.84M | -3.37M | -3.90M | -4.52M | -4.37M |
| EPS Basic | -0.36 | -0.43 | -0.50 | -0.56 | 2.97 |
| Normalized Basic EPS | -0.23 | -0.27 | -0.31 | -0.35 | 1.86 |
| EPS Diluted | -0.36 | -0.43 | -0.50 | -0.56 | 2.97 |
| Normalized Diluted EPS | -0.23 | -0.27 | -0.31 | -0.35 | 1.86 |
| Average Basic Shares Outstanding | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M |
| Average Diluted Shares Outstanding | 7.57M | 7.57M | 7.57M | 7.57M | 7.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |